Christopher J. Twomey's Insider Trades & SAST Disclosures
Christopher J. Twomey's most recent trade in Bionano Genomics Inc was a trade of 30,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 18, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Christopher J. Twomey.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bionano Genomics Inc | Christopher J. Twomey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2024 | 4,434 | 0 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.73 per share. | 22 May 2024 | 4,434 | 11,288 (0%) | 0% | 51.7 | 229,371 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 4,387 | 4,387 | - | - | Restricted Stock Unit | |
| Bionano Genomics Inc | Christopher J. Twomey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2023 | 4,434 | 4,434 | - | - | RSU 2023 05 24 | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2023 | 2,757 | 0 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2023 | 2,757 | 6,854 (0%) | 0% | 0 | Common Stock | |
| Bionano Genomics Inc | Christopher J. Twomey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 164,422 | 164,422 | - | - | Stock Option (right to buy) | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 2,205 | 0 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 2,205 | 4,097 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2022 | 238 | 0 | - | - | Warrant | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.73 per share. | 05 May 2022 | 238 | 5,270 (0%) | 0% | 73.7 | 17,547 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 111.73 per share. | 05 May 2022 | 158 | 5,112 (0%) | 0% | 111.7 | 17,653 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.73 per share. | 05 May 2022 | 135 | 7,658 (0%) | 0% | 73.7 | 9,953 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2022 | 135 | 0 | - | - | Warrant | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 111.73 per share. | 05 May 2022 | 90 | 7,568 (0%) | 0% | 111.7 | 10,056 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Gift of securities by or to the insider at price $ 129.09 per share. | 07 Sep 2021 | 2,500 | 5,032 (0%) | 0% | 129.1 | 322,713 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 123.00 per share. | 07 Sep 2021 | 304 | 7,532 (0%) | 0% | 123 | 37,392 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 115.01 per share. | 02 Sep 2021 | 4,696 | 7,836 (0%) | 0% | 115.0 | 540,077 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 115.00 per share. | 02 Sep 2021 | 4,000 | 7,523 (0%) | 0% | 115 | 460,000 | Common Stock |
| Bionano Genomics Inc | Christopher J. Twomey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2021 | 40,751 | 40,751 | - | - | Stock Option (right to buy) | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 105.00 per share. | 29 Jul 2021 | 5,000 | 15,032 (0%) | 0% | 105 | 525,000 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 105.00 per share. | 29 Jul 2021 | 3,000 | 11,523 (0%) | 0% | 105 | 315,000 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Gift of securities by or to the insider at price $ 104.89 per share. | 29 Jul 2021 | 2,500 | 12,532 (0%) | 0% | 104.9 | 262,213 | Common Stock |
| Bionano Genomics Inc | Christopher J. Twomey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 7,528 | 7,528 | - | - | Stock Option (right to buy) | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2021 | 1,892 | 1,892 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2021 | 1,892 | 0 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 2,205 | 2,205 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2021 | 189 | 0 | - | - | Warrant | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.72 per share. | 18 May 2021 | 189 | 20,189 (0%) | 0% | 73.7 | 13,934 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 89.03 per share. | 18 May 2021 | 157 | 20,032 (0%) | 0% | 89.0 | 13,978 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.73 per share. | 18 May 2021 | 135 | 14,635 (0%) | 0% | 73.7 | 9,953 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2021 | 135 | 0 | - | - | Warrant | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 89.03 per share. | 18 May 2021 | 112 | 14,523 (0%) | 0% | 89.0 | 9,971 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 95.00 per share. | 21 Apr 2021 | 3,401 | 22,500 (0%) | 0% | 95 | 323,095 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Gift of securities by or to the insider at price $ 93.64 per share. | 21 Apr 2021 | 2,500 | 20,000 (0%) | 0% | 93.6 | 234,088 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 95.02 per share. | 21 Apr 2021 | 1,599 | 15,901 (0%) | 0% | 95.0 | 151,934 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 95.02 per share. | 21 Apr 2021 | 1,599 | 25,901 (0%) | 0% | 95.0 | 151,934 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 95.00 per share. | 21 Apr 2021 | 1,401 | 14,500 (0%) | 0% | 95 | 133,095 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 110.06 per share. | 31 Jul 2020 | 5,000 | 30,000 (0%) | 0% | 110.1 | 550,320 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Gift of securities by or to the insider at price $ 106.53 per share. | 31 Jul 2020 | 2,500 | 27,500 (0%) | 0% | 106.5 | 266,313 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 110.00 per share. | 31 Jul 2020 | 2,500 | 17,500 (0%) | 0% | 110 | 275,000 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 100.20 per share. | 02 Jul 2020 | 3,938 | 38,562 (0%) | 0% | 100.2 | 394,574 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 100.02 per share. | 02 Jul 2020 | 2,500 | 20,000 (0%) | 0% | 100.0 | 250,062 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Gift of securities by or to the insider at price $ 101.26 per share. | 02 Jul 2020 | 2,500 | 35,000 (0%) | 0% | 101.3 | 253,150 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 101.17 per share. | 02 Jul 2020 | 1,062 | 37,500 (0%) | 0% | 101.2 | 107,438 | Common Stock |
| Bionano Genomics Inc | Christopher J. Twomey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 44,470 | 44,470 | - | - | Stock Option (Right to Buy) | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2020 | 1,892 | 1,892 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 90.04 per share. | 07 May 2020 | 5,000 | 45,000 (0%) | 0% | 90.0 | 450,214 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Gift of securities by or to the insider at price $ 88.60 per share. | 07 May 2020 | 2,500 | 42,500 (0%) | 0% | 88.6 | 221,488 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 07 May 2020 | 2,500 | 22,500 (0%) | 0% | 90.0 | 225,001 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 80.00 per share. | 30 Apr 2020 | 2,550 | 50,000 (0%) | 0% | 80 | 204,000 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 80.00 per share. | 30 Apr 2020 | 1,758 | 25,000 (0%) | 0% | 80 | 140,640 | Common Stock |
| Bionano Genomics Inc | Christopher J. Twomey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2020 | 45,000 | 45,000 | - | - | Common Stock Warrants (right to buy) | |
| Bionano Genomics Inc | Christopher J. Twomey | Director | Grant, award, or other acquisition of securities at price $ 0.32 per share. | 06 Apr 2020 | 45,000 | 64,500 (0%) | 0% | 0.3 | 14,400 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges